Hard Cover. Condizione: Very Good. No ownership markings; a bit of staining to rear endpapers.
Editore: Syndicat D'initiative, Nivelles, 1984
Da: antoine, Wavre, Belgio
EUR 7,50
Quantità: 1 disponibili
Aggiungi al carrellobroché Bristol illustré. Condizione: Bon État. 54 pages en format 15.5 - 24 cm - nombreuses photos.
Lingua: Francese
Editore: Office du Tourisme, Nivelles, 1997
Da: Librairie Archaion, Bruxelles, Belgio
EUR 12,00
Quantità: 1 disponibili
Aggiungi al carrelloBroché. Condizione: Bon. 64 p., 7 fig. n/b, 11 pl. coul. Inv. 25565.
Lingua: Inglese
Editore: Berlin/ Heidelberg, Springer Berlin., 1999
ISBN 10: 3540625488 ISBN 13: 9783540625483
Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
EUR 24,00
Quantità: 1 disponibili
Aggiungi al carrello1999. 19 x 27 cm. X, 280 S. X, 280 p. 3 illus. in color. hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, dah (Medical Radiology; Radiation Oncology). Sprache: Englisch.
Lingua: Inglese
Editore: Berlin, Springer, 1999
Da: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Germania
Membro dell'associazione: GIAQ
EUR 17,60
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Wie neu. X, 280 S. ; Ill.; 27,5 cm, Like new. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 1120.
Hardcover. Condizione: New. US SELLER SHIPS FAST FROM USA. SHRINK-WRAPPED NEW.
Editore: , Vereniging van Historische Steden van Belgi , 1985, 1985
Da: BOOKSELLER - ERIK TONEN BOOKS, Antwerpen, Belgio
Membro dell'associazione: ILAB
EUR 9,99
Quantità: 1 disponibili
Aggiungi al carrelloOorspronkelijk uitgevers omslag, softcover, 127 pages, Text NL/FR, .nieuwstaat/bon etat!! Architectuurtekeningen uit de historische steden van Belgi = Dessins architecturaux des villes historiques de belgique 0 g.
Da: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Germania
EUR 75,90
Quantità: 1 disponibili
Aggiungi al carrelloHardcover: 19.3 x 0 x 27 cm. 1999. 290 p. Unread book. Like new! 9783540625483 Sprache: Englisch Gewicht in Gramm: 939.
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 112,58
Quantità: 1 disponibili
Aggiungi al carrelloBrand new book. Fast ship. Please provide full street address as we are not able to ship to P O box address.
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
EUR 145,50
Quantità: 1 disponibili
Aggiungi al carrelloBrand new book. Fast ship. Please provide full street address as we are not able to ship to P O box address.
Condizione: Used. pp. x + 280 1st Edition.
EUR 156,22
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. x + 280 56 Figures.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 160,23
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. x + 280.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. x + 280 Softcover Reprint of the Original 1st Edition 1999.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 1999
ISBN 10: 3540625488 ISBN 13: 9783540625483
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 160,49
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, Springer Berlin Heidelberg, 2011
ISBN 10: 3642641407 ISBN 13: 9783642641404
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 160,49
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.
Da: Revaluation Books, Exeter, Regno Unito
EUR 243,84
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. reprint edition. 290 pages. 10.63x0.70x7.60 inches. In Stock.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 260,34
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 292,44
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. Like New. book.
EUR 65,25
Quantità: 1 disponibili
Aggiungi al carrelloCouverture rigide. Condizione: bon. R320052724: 1999. In-Folio. Relié. Bon état, Couv. convenable, Dos satisfaisant, Intérieur frais. 190 pages augmentées de nombreuses photos en couleurs e en noir et blanc in et hors texte - Jaquette en bon, état. Avec Jaquette. . . Classification Dewey : 949.3-Belgique.
Editore: Richelle, 1984
Da: crealivres, La fontennelle, Francia
EUR 23,00
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Good. Envoi rapide Bon état bonne tenue légères rousseurs sur la couverture. in8. 1984. Agrafé. 56 pages. Good.
Lingua: Inglese
Editore: Springer, J.B. Metzler Feb 1999, 1999
ISBN 10: 3540625488 ISBN 13: 9783540625483
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 160,49
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity. 296 pp. Englisch.
Lingua: Inglese
Editore: Springer Berlin Heidelberg Sep 2011, 2011
ISBN 10: 3642641407 ISBN 13: 9783642641404
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 160,49
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -'This volume provides a comprehensive account of the progress that has been made in the treatment of lung cancer. The various therapeutic approaches are documented and appraised, with particular emphasis being placed on the benefits of a multimodality strategy. A balance is sought between US and European perspectives, and all of the authors are recognized experts in the field. 296 pp. Englisch.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 1999
ISBN 10: 3540625488 ISBN 13: 9783540625483
Da: moluna, Greven, Germania
EUR 136,16
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. With contributions by numerous experts|Comprehensive account of the progress in the treatment of lung cancerVarious therapeutic approaches are documented and appraised, with particular emphasis being placed on the benefits of a multimodality strategy.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2011
ISBN 10: 3642641407 ISBN 13: 9783642641404
Da: moluna, Greven, Germania
EUR 136,16
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. With contributions by numerous experts|Comprehensive account of the progress in the treatment of lung cancerVarious therapeutic approaches are documented and appraised, with particular emphasis being placed on the benefits of a multimodality strategy.
Da: Majestic Books, Hounslow, Regno Unito
EUR 209,74
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. x + 280 56 Figures.
Da: preigu, Osnabrück, Germania
EUR 141,20
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Progress and Perspective in the Treatment of Lung Cancer | Paul Van Houtte (u. a.) | Taschenbuch | x | Englisch | 1999 | Springer | EAN 9783540625483 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.